Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Plus Local Surgical Treatment in Retinoblastoma
NCT00179920Phase 2Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Apr 1996
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and etoposide in retinoblastoma (Rb), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoints: Durable control of retinoblastoma, Proportion of eyes in which radiation therapy can be omitted and 1 more. Started Apr 1996; status: completed.
02
Drugs
carboplatinetoposide
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT00179920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179920.